Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Ursodeoxycholic Acid × Tumor-Agnostic × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Standard of Care 3 Oxaliplatin 3 tislelizumab 2 pembrolizumab 2 cemiplimab 2 Radiotherapy 2 Radiation 2 Paclitaxel 2 Data Collection 2 Capecitabine 2 trastuzumab deruxtecan 1 trametinib 1 toripalimab 1 surufatinib 1 sintilimab 1 monalizumab 1 coenzyme Q10 1 blinatumomab 1 anlotinib 1 Whole Genome Sequencing 1 Ursodeoxycholic Acid 1 Ultrasonography 1 Thymopentin 1 Surgical Procedures, Operative 1 Specimen Handling 1 Sequence Analysis, RNA 1 Respiratory Rate 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Psychosocial Intervention 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07378761 2026-01-30

CHILURSO

University Hospital, Montpellier

Phase 2 Not yet recruiting

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡